| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-07 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |